| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | TNON Tenon Medical, Inc. | Foster Steven M | CEO And President | Sell | 27,791 | $1.26 | $35,016.66 | -38.3% | -80.3% | -94.1% | |
| May 23, 2023 | TNON Tenon Medical, Inc. | Ginn Richard | Chief Technology Officer | Sell | 64,990 | $1.26 | $81,887.40 | -43.2% | -80.3% | -94.1% | |
| May 23, 2023 | GKOS Glaukos Corp | Burns Thomas William | Chairman &CEO | Sell | 8 | $60.03 | $480.21 | - | +25.2% | +84.9% | |
| May 22, 2023 | LNSR Lensar, Inc. | Weisner Aimee S69 | Director | Buy | 16,647 | $2.75 | $45,779.25 | +44.2% | +14.2% | +44.1% | |
| May 22, 2023 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 19,401 | $2.25 | $43,694.93 | -2.0% | -60.1% | -84.3% | |
| May 22, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | President, CEO And Chairman | Sell | 10,000 | $45.95 | $459,507.00 | -2.1% | +4.5% | -3.8% | |
| May 22, 2023 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 24,252 | $2.24 | $54,365.71 | -2.0% | -60.1% | -84.3% | |
| May 22, 2023 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 2,400 | $117.58 | $282,192.00 | -3.1% | -12.2% | +9.7% | |
| May 22, 2023 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 6,408 | $2.25 | $14,397.49 | -2.1% | -60.1% | -84.3% | |
| May 22, 2023 | LFWD Lifeward Ltd. | Jasinski Lawrence J62 | Chief Executive Officer | Sell | 11,457 | $0.61 | $6,979.60 | -1.9% | +1.1% | +17.7% | |
| May 22, 2023 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 6,479 | $2.26 | $14,612.09 | -2.3% | -60.1% | -84.3% | |
| May 22, 2023 | INSP Inspire Medical Systems, Inc. | Griffin Jerry C84 | Director | Sell | 529 | $307.52 | $162,678.08 | -5.7% | -29.9% | -51.1% | |
| May 22, 2023 | CNMD Conmed Corp | Peters Stanley W III79 | VP Gm Advanced Surgery | Sell | 1,500 | $120.90 | $181,342.50 | -96.0% | -11.9% | -37.9% | |
| May 22, 2023 | BVS Bioventus Inc. | Bartholdson John A.52 | Director | Buy | 1,315,673 | $1.96 | $2,573,128.08 | +12.7% | +92.6% | +194.7% | |
| May 22, 2023 | BLFS Biolife Solutions Inc | Casdin Partners Master Fund, L.P.53 | 10% Owner | Buy | 74,973 | $22.32 | $1,673,219.91 | +37.5% | -50.8% | -2.5% | |
| May 19, 2023 | LMAT Lemaitre Vascular Inc | Lemaitre George W54 | Chairman And CEO | Sell | 7,098 | $62.67 | $444,809.52 | -0.2% | -11.5% | +25.9% | |
| May 19, 2023 | BRKR Bruker Corp | Kastner Marc A60 | Director | Sell | 11,146 | $75.22 | $838,402.12 | -58.1% | -17.3% | -1.0% | |
| May 19, 2023 | LAB Standard Biotools Inc. | Black Jeffrey G.75 | SVP &Chief Financial Officer | Buy | 85,984 | $2.25 | $193,578.42 | +197.7% | +18.8% | +12.2% | |
| May 19, 2023 | IDXX Idexx Laboratories Inc /de | Ayers Jonathan W63 | Director | Sell | 20,000 | $490.29 | $9,805,770.50 | -0.9% | -0.3% | +11.3% | |
| May 19, 2023 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $7.19 | $143,800.00 | -0.3% | +20.9% | -13.2% | |
| May 19, 2023 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 1,200,000 | $2.19 | $2,631,335.00 | +184.6% | +18.8% | +12.2% | |
| May 19, 2023 | LNSR Lensar, Inc. | Weisner Aimee S69 | Director | Buy | 33,353 | $2.56 | $85,488.27 | +121.0% | +39.4% | +64.1% | |
| May 19, 2023 | LAB Standard Biotools Inc. | Casdin Eli50 | Director, 10% Owner | Buy | 1,200,000 | $2.19 | $2,631,335.00 | +184.6% | +18.8% | +12.2% | |
| May 18, 2023 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 5,165 | $12.59 | $65,027.35 | -4.6% | -15.5% | -84.1% | |
| May 18, 2023 | UTMD Utah Medical Products Inc | Richins Paul O61 | Director | Sell | 700 | $93.47 | $65,429.00 | -3.2% | +0.7% | -25.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.